FDA approves first small aperture IOL for cataract surgery
AcuFocus's IC-8 Apthera IOL features a proprietary small aperture technology that filters out peripheral defocused light and allows only focused light to reach the retina.
Dr. Sicks' #1 tip for managing dry eye
Lindsay A. Sicks, OD, FAAO, shares her number 1 tip for managing dry eye.
SCHs: mild trauma or something more sinister?
Case gives new perspective on subconjunctival hemorrhages
Co-op funds: What they are and how to use them
Diana Canto-Sims, OD, discusses co-op funds with Alessandro Baronti, the president and CEO of the DeRigo Rem.
Apellis receives FDA acceptance, priority review of NDA for GA treatment
If approved, pegcetacoplan—an investigational, targeted C3 therapy—will be the first-ever treatment for GA.
AOA launches Screen Time Alliance, partnership for Eye Deserve More campaign
The first-of-its-kind alliance and latest phase of AOA's national public awareness campaign focuses on the effects of extended time on digital devices and its impact on eye health.
Dr. Michaud's #1 tip for managing dry eye
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, shares his number 1 tip for managing dry eye.
AAO launches search for new CEO; appoints interim CEO
Current CFO Richard Jones named as interim CEO throughout the search.
Study: Children with myopia more likely to have depression, anxiety
A recent study by Orbis International reports that children with myopia experienced significantly higher levels of depression and anxiety than their peers without vision impairment.
Imaging technology helps in scanning for retinal diseases
Advancements enable better diagnosis, treatment of patients.
New 2-year data supports faricimab-svoa for treatment of wet AMD
Presented during the 2022 ASRS meeting, results find that over 60% of participants could be treated every 4 months at 2 years—an increase from 45% at year 1.
Study confirms supplements slow AMD progression
A decade after the conclusion of the NIH-funded AREDS2 study, researchers found that the AREDS2 formula also reduces the risk of lung cancer.
Preparation is key to fighting dry eye while traveling
Best practices to help patients enjoy their trip to the fullest.
Dr. Coyne's #1 tip for managing dry eye
Alissa M. Coyne, OD, FAAO, FASOS, gives her number 1 tip for managing dry eye.
Q&A: What role does corneal hysteresis play in determining glaucoma risk?
Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part three.
Q&A: How is corneal hysteresis measured?
Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part two.
Bausch + Lomb, Novaliq submit NDA for NOV03 to treat DED associated with MGD
Drug submission of the first water-free therapy took place at the end of June, according to the companies.
Novartis acquires Kedalion Therapeutics and its ocular delivery platform
The company intends to develop the AcuStream technology for potential use with its current and future front-of-eye therapies, which may include lifitegrast ophthalmic solution for the treatment of dry eye disease.
Interventional management of glaucoma offers big advantages
4 objectives are key for embracing a patient-focused form of care.
Q&A: What is corneal hysteresis?
Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part one.
